Latest News Archive

Please select Category, Year, and then Month to display items

UFS responds to posts trending on Twitter on 4 June 2020

04 June 2020 | Story Lacea Loader

It has come to the attention of the University of the Free State (UFS) that false and inaccurate statements have been circulating on Twitter on 4 June 2020, claiming that its students were not equipped or supported to study remotely during the COVID-19 lockdown. The UFS believes that it is important to engage in dialogue to correct any misconceptions and inaccuracies that are at risk of being perpetuated.

Contrary to these reports, the UFS has invested much time and resources in the development and deployment of low-tech online and distance approaches to learning and teaching. Since March 2020, the university has undertaken extensive measures to support its students after classes were suspended and to ensure the continuation of the academic programme.

Statements on Twitter include a number of inaccuracies, which the university wants to correct:

• The Institutional Student Representative Council (ISRC) was not suspended by the Rector and Vice-Chancellor, Prof Francis Petersen. In fact, the university management regularly meets with the ISRC on matters of concern to them. Student representatives also serve on a number of institutional committees – both before and during the national lockdown.
• No deregistration of any students has taken place.
• Since the end of April 2020, structured and managed data was provided to students to obtain access to academic content as well as to the academic platforms for free. However, to access this free data, students need to download the GlobalProtect app – this was communicated numerously and explained to students. The university’s ICT Services will provide video and technical guides to all students to assist them with downloading the app.
• As of June 2020, all allowances for which students qualify and which are approved by NSFAS, have been paid by the university.
• Although online learning provides a solution to continue with programme delivery, the university is deeply aware of the fact that access may be a barrier – especially during these extraordinary times. To assist vulnerable students, a total of 3 500 laptops have been procured by the UFS, enabling the university to assist eligible students in accessing the online platforms, obtaining learning material, and engaging with lecturers. The university is in the process of distributing the laptops to students who qualify. The Department of Higher Education, Science and Innovation’s process to provide laptops to students is separate from the 3 500 laptops procured by the UFS.

The UFS remains committed to supporting its students in response to COVID-19 and is looking forward to working as a community to prepare for the institution’s response to the new challenges of responsibly returning to campus life from June 2020 onward. As staff and students start returning to the institution in a phased approach this month, the UFS will continue to comply with all applicable governmental directives and health guidelines to ensure the safety, health, and well-being of its students and staff.

Released by:
Lacea Loader (Director: Communication and Marketing)
Telephone: +27 51 401 2584 | +27 83 645 2454
Email: news@ufs.ac.za | loaderl@ufs.ac.za

News Archive

Nuclear Medicine on the forefront of cancer research

2017-07-10

Dr Je’nine Horn-Lodewyk’s tumour detection method
could be the cost-effective breakthrough needed to decrease
the mortality rate in breast cancer patients.
Photo: Anja Aucamp

The field of Nuclear Medicine in South Africa and the rest of the world are expanding rapidly due to the development of hybrid cameras and new radiopharmaceuticals. These developments have a huge impact on the diagnosis and therapy of cancer.

The most advanced of these cameras, Positron emission tomography combined with normal CTs (PETCT), are not yet widely available in South Africa due to the cost of the cameras and the radiopharmaceuticals. A more cost-effective alternative can be of great benefit. To achieve this, the focus should be on developing new radiopharmaceuticals that can be used with the current cost-effective gamma cameras, according to University of the Free State researcher, Dr Je’nine Horn-Lodewyk from the Department of Nuclear Medicine.

Fluorodeoxyglucose (18F-FDG), a radiolabelled glucose analogue, is currently the radiopharmaceutical most commonly used in PET/CT imaging for mainly oncology indications. Although it is considered the gold standard for imaging in several malignancies, it does have certain disadvantages. An 18F-FDG PET/CT diagnostic imaging study can cost between R25 000 and R35 000 for a single patient in the private sector. The 18F-FDG is also more radioactive, which requires much stricter handling and shielding to avoid high radiation dosages to staff and patients.

Successful research potential innovative solution
In the search for the ideal radiopharmaceutical for tumour detection, the South African National Nuclear Energy Corporation (Necsa) developed a local synthesis process for ethylenedicysteine-deoxyglucose (EC-DG). EC-DG is also a glucose analogue similar to FDG. They succeeded in labelling the compound with Technetium-99-metastable-pertechnetate (99mTcO4-), the most common nuclear medicine isotope used for approximately 95% of nuclear medicine procedures, creating 99mTc-EC-DG.

In partnership with Dr Horn-Lodewyk, this compound was successfully used in various animal models and clinical scenarios, resulting in approval by the Medicine Control Council to use it in a human study. Research is also planned in order to investigate diagnostic accuracy in other cancers like lymphoma. The end result of this research can produce a radiopharmaceutical that is cost effective, does not require the use of costly specialised equipment, has no significant side-effects, no special patient preparation, renders late imaging possible, and has decreased radiation risks.

Dr Horn-Lodewyk is grateful for the support of her mentor, Prof Anton Otto, as well as Dr Gert Engelbrecht, Head of the Department of Nuclear Medicine, Prof Jan Rijn Zeevaart from North-West University’s Preclinical Drug Development Platform and Necsa, and Judith Wagener from Necsa. This innovative research would also not have been possible without the financial assistance of Dr Glen Taylor and Eleanor van der Westhuizen in the Directorate of Research Development.

Back

Economic and Management Sciences

Education

Health Sciences

The Humanities

Law

Natural and Agricultural Sciences

Theology and Religion

Open Distance Learning

Business School

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept